Pasotuxizumab, a Bite ® Immune Therapy for Castration-Resistant Prostate Cancer: Phase I, Dose-Escalation Study Findings

Hummel, Horst-Dieter, Kufer, Peter, Grüllich, Carsten · Immunotherapy · 2021